The risk of dying from the most common form of primary liver cancer is about 30% higher for patients with low household ...

Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC ... and echo features including septa, calcification and liquefaction within the tumors. Results: Compared with the children ...

Systemic therapy represents the standard of care treatment for patients with advanced hepatocellular carcinoma (HCC). Given ...

Hepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive diagnostic/prognostic biomarkers for early detection of HCC are still lacking.

The FDA approved nivolumab and ipilimumab for unresectable or metastatic hepatocellular carcinoma, a prevalent and deadly liver cancer in the U.S. CHECKMATE-9DW trial results showed improved ...

The clinical trial will include nearly 150 patients with advanced hepatocellular carcinoma that expresses glypican-3.

The FDA has granted full approval to Bristol Myers Squibb’s (BMS) dual immunotherapy regimen of Opdivo (nivolumab) plus Yervoy (ipilimumab) for adults with unresectable or metastatic hepatocellular ...

The images were transferred to the workstation. A series of ultrasound features of the lesions (number, size, location, calcification, liquefaction, septa within the mass), together with the ...